Related Experiment Video
Updated: May 13, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Complex HeartMate II infection treated with pump exchange to HeartWare HVAD
Travis Abicht1, Robert Gordon, Karen Meehan
1Department of Surgery, Division of Cardiac Surgery, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine, Chicago, IL 60611-2968, USA.
Abstract:
Left ventricular assist device (LVAD) infections continue to present a serious challenge in both the destination therapy and the bridge to transplant patient populations. As devices are supporting patients longer due to increased durability, infections can evolve and worsen over time. Complex infections, resistant to standard pharmacologic management, require a more aggressive approach to treatment. A series of patients supported by HeartMate II (HMII) LVADs, treated for multidrug resistant complex driveline infections, failed antibiotic therapy and then underwent device exchange. In each case, the HMII device was exchanged for a HeartWare HVAD as we felt its small size and flexible driveline were advantageous properties when dealing with patients with a complex driveline or pump infection.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiac Catheterization II: Right Heart Catheterization
Endocarditis III: Medical Management

